A Neuroendocrine Tumor Specialty Center in New Orleans’ (NOLANETS) Response to Patient Care During the COVID‐19 Pandemic

This commentary outlines the steps taken by the New Orleans Louisiana Neuroendocrine Tumor Specialists to minimize the risk of patient exposure to SARS‐CoV‐2 but to continue to provide safe, high‐quality care during the COVID‐19 pandemic.

Detalles Bibliográficos
Autores principales: Ramirez, Robert A., Bren‐Mattison, Yvette, Thiagarajan, Ramcharan, Boudreaux, J. Philip, Marsala, Andrew J., Ryan, Pamela, Maluccio, Mary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356714/
https://www.ncbi.nlm.nih.gov/pubmed/32369669
http://dx.doi.org/10.1634/theoncologist.2020-0279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356714/
https://www.ncbi.nlm.nih.gov/pubmed/32369669
http://dx.doi.org/10.1634/theoncologist.2020-0279

Ejemplares similares